Pleural Effusion Clinical Presentation
- Author: Jeffrey Rubins, MD; Chief Editor: Zab Mosenifar, MD more...
History
A detailed medical history should be obtained from all patients presenting with a pleural effusion, as this may help to establish the etiology. For example, a history of chronic hepatitis or alcoholism with cirrhosis suggests hepatic hydrothorax or alcohol-induced pancreatitis with effusion. Recent trauma or surgery to the thoracic spine raises the possibility of a CSF leak. The patient should be asked about a history of cancer, even remote, as malignant pleural effusions can develop many years after initial diagnosis.
An occupational history should also be obtained, including potential asbestos exposure, which could predispose the patient to mesothelioma or asbestos pleural effusion. The patient should also be asked about medications they are taking.[4]
The clinical manifestations of pleural effusion are variable and often are related to the underlying disease process. The most commonly associated symptoms are progressive dyspnea, cough, and pleuritic chest pain.
Dyspnea
Dyspnea is the most common symptom associated with pleural effusion and is related more to distortion of the diaphragm and chest wall during respiration than to hypoxemia. In many patients, drainage of pleural fluid alleviates symptoms despite limited improvement in gas exchange. Drainage of pleural fluid may also allow the underlying disease to be recognized on repeat chest radiographs. Note that dyspnea may be caused by the condition producing the pleural effusion, such as underlying intrinsic lung or heart disease, obstructing endobronchial lesions, or diaphragmatic paralysis, rather than by the effusion itself.
Cough
Cough in patients with pleural effusion is often mild and nonproductive. More severe cough or the production of purulent or bloody sputum suggests an underlying pneumonia or endobronchial lesion.
Chest pain
The presence of chest pain, which results from pleural irritation, raises the likelihood of an exudative etiology, such as pleural infection, mesothelioma, or pulmonary infarction.[18]
Pain may be mild or severe. It is typically described as sharp or stabbing and is exacerbated with deep inspiration. Pain may be localized to the chest wall or referred to the ipsilateral shoulder or upper abdomen, usually because of diaphragmatic involvement. Pain often diminishes in intensity as the pleural effusion increases in size.
Additional symptoms
Other symptoms in association with pleural effusions may suggest the underlying disease process. Increasing lower extremity edema, orthopnea, and paroxysmal nocturnal dyspnea may all occur with congestive heart failure.
Night sweats, fever, hemoptysis, and weight loss should suggest TB. Hemoptysis also raises the possibility of malignancy, other endotracheal or endobronchial pathology, or pulmonary infarction. An acute febrile episode, purulent sputum production, and pleuritic chest pain may occur in patients with an effusion associated with pneumonia.
Physical Examination
Physical findings in pleural effusion are variable and depend on the volume of the effusion. Generally, there are no physical findings for effusions smaller than 300 mL. With effusions larger than 300 mL, findings may include the following:
- Dullness to percussion, decreased tactile fremitus, and asymmetrical chest expansion, with diminished or delayed expansion on the side of the effusion, are the most reliable physical findings of pleural effusion.[19, 20]
- Mediastinal shift away from the effusion - This is observed with effusions of greater than 1000 mL; displacement of the trachea and mediastinum toward the side of the effusion is an important clue to obstruction of a lobar bronchus by an endobronchial lesion, which can be due to malignancy or, less commonly, to a nonmalignant cause, such as a foreign body.
- Diminished or inaudible breath sounds
- Egophony ("e" to "a" changes) at the most superior aspect of the pleural effusion
- Pleural friction rub
Other physical findings, as follows, may suggest the underlying cause of the pleural effusion:
- Peripheral edema, distended neck veins, and S3 gallop suggest congestive heart failure. Edema may also be a manifestation of nephrotic syndrome; pericardial disease; or, combined with yellow nails, the yellow nail syndrome.
- Cutaneous changes with ascites suggest liver disease
- Lymphadenopathy or a palpable mass suggests malignancy.[4]
Diaz-Guzman E, Dweik RA. Diagnosis and management of pleural effusions: a practical approach. Compr Ther. Winter 2007;33(4):237-46. [Medline].
Noppen M. Normal volume and cellular contents of pleural fluid. Curr Opin Pulm Med. Jul 2001;7(4):180-2. [Medline].
Sahn SA. The differential diagnosis of pleural effusions. West J Med. Aug 1982;137(2):99-108. [Medline]. [Full Text].
Sahn SA. Pleural effusions of extravascular origin. Clin Chest Med. Jun 2006;27(2):285-308. [Medline].
Light RW. The undiagnosed pleural effusion. Clin Chest Med. Jun 2006;27(2):309-19. [Medline].
Culotta R, Taylor D. Diseases of the pleura. In: Ali J, Summer WR, Levitzky MG, eds. Pulmonary Pathophysiology. 2nd ed. New York: Lange Medical Books/McGraw-Hill; 2005:194-212.
Askegard-Giesmann JR, Caniano DA, Kenney BD. Rare but serious complications of central line insertion. Semin Pediatr Surg. May 2009;18(2):73-83. [Medline].
Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med. Apr 2009;30(2):154-60. [Medline].
Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. Jan 2008;13(1):5-20. [Medline].
Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration. 2008;75(4):361-71. [Medline].
Sahn SA. The value of pleural fluid analysis. Am J Med Sci. Jan 2008;335(1):7-15. [Medline].
Beers SL, Abramo TJ. Pleural effusions. Pediatr Emerg Care. May 2007;23(5):330-4; quiz 335-8. [Medline].
Yinon Y, Kelly E, Ryan G. Fetal pleural effusions. Best Pract Res Clin Obstet Gynaecol. Feb 2008;22(1):77-96. [Medline].
Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. Jan 2000;117(1):73-8. [Medline].
Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med. Jul 2009;15(4):380-7. [Medline].
Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. Aug 2010;65 Suppl 2:ii32-40. [Medline].
Khaleeq G, Musani AI. Emerging paradigms in the management of malignant pleural effusions. Respir Med. Jul 2008;102(7):939-48. [Medline].
Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration. 2008;75(1):4-13. [Medline].
Wong CL, Holroyd-Leduc J, Straus SE. Does this patient have a pleural effusion?. JAMA. Jan 21 2009;301(3):309-17. [Medline].
Kalantri S, Joshi R, Lokhande T, Singh A, Morgan M, Colford JM Jr, et al. Accuracy and reliability of physical signs in the diagnosis of pleural effusion. Respir Med. Mar 2007;101(3):431-8. [Medline].
Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. Oct 1972;77(4):507-13. [Medline].
Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest. Apr 1997;111(4):970-80. [Medline].
Light RW. Use of pleural fluid N-terminal-pro-brain natriuretic peptide and brain natriuretic peptide in diagnosing pleural effusion due to congestive heart failure. Chest. Sep 2009;136(3):656-8. [Medline].
Romero-Candeira S, Fernandez C, Martin C, Sanchez-Paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med. Jun 15 2001;110(9):681-6. [Medline].
Burgess LJ. Biochemical analysis of pleural, peritoneal and pericardial effusions. Clin Chim Acta. May 2004;343(1-2):61-84. [Medline].
Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Hoffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J. Jul 2006;28(1):144-50. [Medline].
Porcel JM, Martinez-Alonso M, Cao G, Bielsa S, Sopena A, Esquerda A. Biomarkers of heart failure in pleural fluid. Chest. Sep 2009;136(3):671-7. [Medline].
Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. Aug 2011;66(8):658-62. [Medline].
Abouzgheib W, Bartter T, Dagher H, Pratter M, Klump W. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest. Apr 2009;135(4):999-1001. [Medline].
Swiderek J, Morcos S, Donthireddy V, et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest. Jan 2010;137(1):68-73. [Medline].
Sakuraba M, Masuda K, Hebisawa A, Sagara Y, Komatsu H. Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy. Ann Thorac Cardiovasc Surg. Oct 2009;15(5):294-6. [Medline].
Gurung P, Goldblatt M, Huggins JT, et al. Pleural Fluid Analysis, Radiographic, Sonographic and Echocardiographic Characteristics of Hepatic Hydrothorax. Chest. Jan 27 2011;[Medline].
Duncan DR, Morgenthaler TI, Ryu JH, Daniels CE. Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest. May 2009;135(5):1315-20. [Medline].
[Best Evidence] Metintas M, Ak G, Dundar E, et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest. Jun 2010;137(6):1362-8. [Medline].
Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. Dec 2009;9(6):961-4. [Medline].
Fysh ET, Waterer GW, Kendall P, Bremner P, Dina S, Geelhoed E, et al. Indwelling Pleural Catheters Reduce Inpatient Days over Pleurodesis for Malignant Pleural Effusion. Chest. Mar 8 2012;[Medline].
Goligher EC, Leis JA, Fowler RA, et al. Utility and safety of draining pleural effusions in mechanically ventilated patients: a systematic review and meta-analysis. Crit Care. Feb 2 2011;15(1):R46. [Medline].
Feller-Kopman D, Parker MJ, Schwartzstein RM. Assessment of pleural pressure in the evaluation of pleural effusions. Chest. Jan 2009;135(1):201-9. [Medline].
West SD, Davies RJ, Lee YC. Pleurodesis for malignant pleural effusions: current controversies and variations in practices. Curr Opin Pulm Med. Jul 2004;10(4):305-10. [Medline].
Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;CD002916. [Medline].
Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. Feb 2000;69(2):369-75. [Medline].
Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. May 2006;29(5):829-38. [Medline].
Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. Mar 2005;127(3):909-15. [Medline].

